PPARδ activation inhibits angiotensin II induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+ signaling pathway

Journal of Cellular Biochemistry

Volumn 106, Issue 5, 2009, Pages 823-834

  Lee, Kuy Sook ^a   Park, Jin Hee ^a   Lee, Seahyoung ^b   Lim, Hyun Joung ^a   Park, Hyun Young ^a  

^a Korea National Institute of Health   (South Korea)

^b INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

Calcium; Cardiomyocyte hypertrophy; Focal adhesion kinase; PPARd

Indexed keywords

4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; ANGIOTENSIN II; CALCIUM; FOCAL ADHESION KINASE; LEUCINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SMALL INTERFERING RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART HYPERTROPHY; HEART MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; GENETICS; HYPERTROPHY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ADENOVIRIDAE;

ANGIOTENSIN II; ANIMALS; CALCIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HYPERTROPHY; MYOCYTES, CARDIAC; PPAR DELTA; RATS; SIGNAL TRANSDUCTION;

EID: 65349162821     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22038     Document Type: Article

References (37)

1. Berger J, Leibowitz MD, Doebber TW, Elbrecht A, Zhang B, Zhou G, Biswas C, Cullinan CA, Hayes NS, Li Y, Tanen M, Ventre J, Wu MS, Berger GD, Mosley R, Marquis R, Santini C, Sahoo SP, Tolman RL, Smith RG, Moller DE. 1999. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPAR-delta ligands produce distinct biological effects. J Biol Chem 274:6718-6725.
2. Booz GW, Baker KM. 1996. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28:635- 640.
3. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q. 2004. Cardiomyocyte-restricted per-oxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10:1245-1250.
4. Eble DM, Strait JB, Govindarajan G, Lou J, Byron KL, Samarel AM. 2000. Endothelin-induced cardiac myocyte hypertrophy: Role for focal adhesion kinase. Am J Physiol Heart Circ Physiol 278:H1695-H1707.
5. Gardner OS, Dewar BJ, Graves LM. 2005. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: An example of nongenomic signaling. Mol Pharmacol 68:933-941.
6. Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B, van Bilsen M. 2003. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 92:518-524.
7. Govindarajan G, Eble DM, Lucchesi PA, Samarel AM. 2000. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells. Circ Res 87:710-716.
8. Han J-K, Lee H-S, Yang H-M, Hur J, Jun. S-I, Kim J-Y, C C-H, Koh G-Y, Peters JM, Park K-W, Cho H-J, Lee H-Y, Kang H-J, Oh B-H, Park Y-B, Kim H-S. 2008. Peroxisome proliferator-activated receptor-d agonist enhances vascu-logenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Circulation 118:1021-1033.
9. Heineke J, Molkentin JD. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589-600.
10. Hildebrand JD, Schaller MD, Parsons JT. 1993. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 123:993-1005.
11. Hunt RA, Bhat GJ, Baker KM. 1999. Angiotensin II-stimulated induction of sis-inducing factor is mediated by pertussis toxin-insensitive G (q) proteins in cardiac myocytes. Hypertension 34:603-608.
12. Kovacic-Milivojevic B, Roediger F, Almeida EA, Damsky CH, Gardner DG, Ilic D. 2001. Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy. Mol Biol Cell 12:2290-2307.
13. Leduc I, Meloche S. 1995. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem 270:4401-4404.
14. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566.
15. Li X, Lee JW, Graves LM, Earp HS. 1998. Angiotensin II stimulates ERK via two pathways in epithelial cells: Protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17:2574-2583.
16. Lorell BH, Carabello BA. 2000. Left ventricular hypertrophy: Pathogenesis, detection, and prognosis. Circulation 102:470-479.
17. McWhinneyCD, HuntRA, Conrad KM, DostalDE, Baker KM. 1997. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes. J Mol Cell Cardiol 29:2513-2524.
18. Miyata S, Haneda T. 1994. Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor. Am J Physiol 266: H2443-H2451.
19. Parsons JT. 1996. Integrin-mediated signalling: Regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol 8:146-152.
20. Planavila A, Rodriguez-Calvo R, Jove M, Michalik L, Wahli W, Laguna JC, Vazquez-Carrera M. 2005. Peroxisome proliferator-activated receptor beta /delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res 65:832-841.
21. Qin J, Liu ZX. 2006. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes. Acta Pharmacol Sin 27:1159-1164.
22. Sabri A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, Lucchesi PA. 1998. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res 83:841-851.
23. Sadoshima J, Izumo S. 1993. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibro-blasts. Critical role of the AT1 receptor subtype. Circ Res 73:413-423.
24. Sadoshima J, Izumo S. 1996. The heterotrimeric G q protein-coupled angio-tensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 15:775-787.
25. Salazar EP, Rozengurt E. 2001. Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J Biol Chem 276:17788-17795.
26. Schlaepfer DD, Hauck CR, Sieg DJ. 1999. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71:435-478.
27. Seimandi M, Lemaire G, Pillon A, Perrin A, Carlavan I, Voegel JJ, Vignon F, Nicolas JC, Balaguer P. 2005. Differential responses of PPARalpha, PPAR-delta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. Anal Biochem 344:8-15.
28. Sugden PH. 2002. Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies. J Card Fail 8:S359-S369.
29. 2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J Biol Chem 276:48950-48955.
30. Taylor JM, Rovin JD, Parsons JT. 2000. A role for focal adhesion kinase in phenylephrine-induced hypertrophy of rat ventricular cardiomyocytes. J Biol Chem 275:19250-19257.
31. Torsoni AS, Constancio SS, Nadruz W, Jr., Hanks SK, Franchini KG. 2003. Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes. Circ Res 93:140-147.
32. Turner CE, Pietras KM, Taylor DS, Molloy CJ. 1995. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J Cell Sci 108 (Pt 1) : 333- 342.
33. 2 toxicity. Am J Physiol 276:H167-H175.
34. Weng YI, Shukla SD. 2002. Angiotensin II activation of focal adhesion kinase and pp60c-Src in relation to mitogen-activated protein kinases in hepato-cytes. Biochim Biophys Acta 1589:285-297.
35. Wilkins BJ, Molkentin JD. 2004. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322: 1178-1191.
36. Yin G, Yan C, Berk BC. 2003. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 35:780-783.
37. Zhu T, Goh EL, LeRoith D, Lobie PE. 1998. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130 (Cas) and CrkII. Resultant activation of c-Jun. N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem 273:33864-33875.